Aurora Cannabis (ACB) Other Working Capital Changes (2021 - 2022)

Aurora Cannabis (ACB) reported Other Working Capital Changes of -$721968.9 for Q4 2022, down 125.8% year-over-year from $2.8 million in Q4 2021, and up 63.81% quarter-over-quarter from -$2.0 million in Q3 2022.

Aurora Cannabis (ACB) Other Working Capital Changes (2021 - 2022) Analysis & Trends

Aurora Cannabis (ACB) has 2 years of Other Working Capital Changes data on file, last reported at -$721968.9 in Q4 2022.

  • Other Working Capital Changes for Q4 2022 came in at -$721968.9, down 125.8% year-over-year; the trailing twelve-month figure through Dec 2022 was -$824859.7 (changed N/A YoY), and the FY2023 annual result was $11835.1, changed N/A from the prior year.
  • Other Working Capital Changes rose to -$721968.9 in Q4 2022 per ACB's latest filing, from -$2.0 million in the prior quarter.
  • Over five years, Other Working Capital Changes peaked at $2.8 million in Q4 2021 and troughed at -$2.1 million in Q3 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn
10 Liquidia 5.63 Bn 5.40 Bn 121.79 Mn

Historic Data

Download Data
DateValue
Dec 31, 2022 -721,968.88
Dec 31, 2022 -721,968.88
Sep 30, 2022 -2.00 Mn
Sep 30, 2022 -2.00 Mn
Jun 30, 2022 -905,913.46
Jun 30, 2022 -905,913.46
Dec 31, 2021 2.80 Mn
Dec 31, 2021 2.80 Mn
Sep 30, 2021 -2.07 Mn
Sep 30, 2021 -2.07 Mn